Errors in the treatment of tuberculosis in Baltimore

Chest

Volumn 117, Issue 3, 2000, Pages 734-737

  Rao, Sudeep N ^a,b   Mookerjee, Anuradha L ^a   Obasanjo, Olugbenga O ^a   Chaisson, Richard E ^a,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug resistance; Private providers; Treatment error; Tuberculosis treatment

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; CLINICAL PROTOCOL; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT FAILURE; TUBERCULOSIS;

EID: 0034069395     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.3.734     Document Type: Article

References (16)

1. 1 Centers for Disease Control and Prevention. Expanded tuberculosis surveillance and tuberculosis morbidity: United States, 1993. MMWR Morb Mortal Wkly Rep 1994; 43:361-365
2. 2 Frieden TR, Fujiwara PI, Washko RM, et al. Tuberculosis in New York City: turning the tide. N Engl J Med 1995; 333:229-233
3. 3 Miller B, Rosenbaum S, Stange PV, et al. Tuberculosis control in a changing health care system: model contract specifications for managed care organizations. Clin Infect Dis 1998; 27:677-686
4. 4 Bass JB Jr, Farer LS, Hopewell PC, et al. Treatment of tuberculosis and tuberculosis infection in adults and children: American Thoracic Society and the Centers for Disease Control and Prevention. Am J Respir Crit Care Med 1994; 149:1359-1374
5. 5 Frieden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328:521-526
6. 6 Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA 1993; 270:65-68
7. 7 Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multi-drug resistance: recommendation of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1993; 42:1-8
8. 8 Liu Z, Shilkret KL, Finelli L. Initial drug regimens for the treatment of tuberculosis: evaluation of physician prescribing practices in New Jersey, 1994 to 1995. Chest 1998; 113:1446-1451
9. 9 Chaulk CP, Moore-Rice K, Rizzo R, et al. 11 years of community-based directly observed therapy for tuberculosis. JAMA 1995; 274:945-951
10. 10 Chaulk CP, Pope DS. The Baltimore City Health Department program of directly observed therapy for tuberculosis. Clin Chest Med 1997; 18:149-154
11. 11 American Thoracic Society. Control of tuberculosis in the United States. Am Rev Respir Dis 1992; 146:1623-1633
12. 12 McAnulty JM, Fleming DW, Hawsley M, et al. Missed opportunities for tuberculosis prevention. Arch Intern Med 1995; 155:713-716
13. 13 Liu Z, Shilkret KL, Ellis HM. Predictors of sputum conversions among patients with tuberculosis in the era of tuberculosis resurgence. Arch Intern Med 1999; 159:1110-1116
14. 14 Kitahara MM, Koepsell TD, Deyo RA, et al. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med 1996; 334:701-706
15. 15 Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144:745-749
16. 16 Uplekar M, Juvekar S, Morankar S, et al. Tuberculosis patients and practitioners in private clinics in India. Int J Tuberc Lung Dis 1998; 2:324-329